All news

Officer John Cox proposes selling 5,513 Dyne Therapeutics (DYN) shares around November 13, 2026.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

John Cox, an officer at Dyne Therapeutics (DYN), has filed a Form 144 notice proposing to sell 5,513 common shares, valued at approximately $92,751.00, with an anticipated sale date of November 13, 2026. This proposed sale follows a previous sale of 5,658 common shares on September 8, 2026, which yielded gross proceeds of

Read original source

DYN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.